Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Intellectual disability-short stature-hypertelorism syndrome is a rare genetic syndromic intellectual disability affecting males characterized by short stature, mild to moderate intellectual deficits, craniofacial dysmorphism (prominent broad 'square' forehead, hypertelorism, depressed nasal bridge, broad nasal tip and anteverted nares) and early hypotonia present only until the age of 2. There have been no further descriptions in the literature since the original article in 1991 and it has been suggested that this condition represents an example of FG syndrome.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for intellectual disability-short stature-hypertelorism syndrome.
104 publications have been identified in PubMed for intellectual disability-short stature-hypertelorism syndrome. Kisho has analyzed 80 by research type. Research spans Review / Meta-Analysis (63%), Basic Science / Preclinical (18%), and Epidemiology / Natural History (9%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 50 | 63% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 9:55 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research |
14 |
18% |
Disease patterns and progression | 7 | 9% |
Patient case studies | 5 | 6% |
Clinical study results | 4 | 5% |
Ferri C (2026). [PMID: 41798958](https://pubmed.ncbi.nlm.nih.gov/41798958/). *Front Immunol*. [Review / Meta-Analysis]
Lee S (2026). [PMID: 41206258](https://pubmed.ncbi.nlm.nih.gov/41206258/). *Am J Geriatr Psychiatry*. [Review / Meta-Analysis]
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Clinical Trial Publication]
Yacoub MR (2025). [PMID: 40747632](https://pubmed.ncbi.nlm.nih.gov/40747632/). *Curr Opin Allergy Clin Immunol*. [Review / Meta-Analysis]
Laaraje A (2025). [PMID: 41693193](https://pubmed.ncbi.nlm.nih.gov/41693193/). *Pediatr Endocrinol Diabetes Metab*. [Case Report / Case Series]
Biglari S (2025). [PMID: 40101970](https://pubmed.ncbi.nlm.nih.gov/40101970/). *J Med Genet*. [Basic Science / Preclinical]
Yildizdal S (2025). [PMID: 39848875](https://pubmed.ncbi.nlm.nih.gov/39848875/). *J Craniomaxillofac Surg*. [Clinical Trial Publication]
Sahoo SS (2025). [PMID: 39475954](https://pubmed.ncbi.nlm.nih.gov/39475954/). *Blood*. [Review / Meta-Analysis]
Cardoso DL (2025). [PMID: 40393099](https://pubmed.ncbi.nlm.nih.gov/40393099/). *Eur J Radiol*. [Review / Meta-Analysis]